Series A - VLP Therapeutics
Investment Firm
Overview
VLP is a biotech company with a mission to address unmet medical needs worldwide and expand the frontiers of vaccine treatment.
Announced Date
Mar 15, 2021
Funding Type
Series A
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
3
| Investor Name |
|---|
 Robert Hisaoka |
 Miyako Capital |
Round Details and Background
VLP Therapeutics raised $16000000 on 2021-03-15 in Series A
VLP is a biotech company with a mission to address unmet medical needs worldwide and expand the frontiers of vaccine treatment.
Company Funding History
4
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Dec 12, 2018 |  Grant - VLP Therapeutics | 1 | - | 3.9M |
| Mar 15, 2021 | Series A - VLP Therapeutics | 6 | - | 16.0M |
| Dec 27, 2021 | Series A - VLP Therapeutics | 6 | - | 21.0M |
| Jul 14, 2016 | Grant - VLP Therapeutics | - | 2.4M |
Recent Activity
There is no recent news or activity for this profile.